{
    "code": "01022615",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01022615",
    "time": "2016-11-18 11:56:44",
    "許可證字號": "衛署藥製字第022615號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/03\/18",
    "註銷理由": "屆期未申請展延",
    "有效日期": "89\/04\/10",
    "發證日期": "69\/12\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102261509",
    "中文品名": "腸力錠",
    "英文品名": "CHUNLI TABLETS &quot;S.M.&quot;",
    "適應症": "消化不良、消化不良引起之胃腸疾患、消化機能減退或障礙",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "07須經醫師指示使用",
    "主成分略述": [
        "NEWLASE,DIASTASEBIO-,LIPASE"
    ],
    "限制項目": "09委託製造",
    "申請商名稱": "1310019200  聖秘藥品企業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0816219300  林化學製藥股份有限公司",
        "製造廠廠址": "台南巿仁和路８號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400002700",
            "成分名稱": "NEWLASE",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5616000780",
            "成分名稱": "DIASTASE BIO-",
            "含量描述": "(1000) 30",
            "含量": "",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5616000900",
            "成分名稱": "LIPASE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ]
}